Laekna, Inc. 來凱醫藥有限公司

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chau, Kwok Keung 鄒國強 INED 181 181
2 Gu, Justin Xiangju 顧祥巨 ED 1,973 424 70 2,895 5,362
3 Ji, Dongmei 吉冬梅 NED
4 Li, Min (1961) 利民 INED 181 181
5 Lu, Chris Xiangyang 呂向陽 Ch, CEO, Fdr 2,244 385 70 4,994 7,693
6 Sun, Yuan (1988) 孫淵 NED
7 Wang, David Guowei 王國瑋 NED
8 Xie, Ling (1970) 謝玲 ED 1,768 480 52 3,019 5,319
9 Yin, Xudong 尹旭東 INED 181 181
Total 543 5,985 1,289 192 10,908 18,917

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,095 6,531 1,496 193 15,612 24,927 Report
2023-12-31 543 5,985 1,289 192 10,908 18,917 Report
2022-12-31 0 5,285 549 195 6,305 12,334
Total 1,638 17,801 3,334 580 32,825 56,178

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top